Reliability of serum neurofilament light and glial fibrillary acidic protein for detecting disease activity upon discontinuation of first-line disease-modifying therapy in stable multiple sclerosis (DOT-MS).

Fung WH, Wessels MHJ, Coerver EME, de Beukelaar J, Bouvy WH, Canta LR, Gerlach OHH, Hoitsma E, Hoogervorst ELJ, de Jong BA, Kalkers NF, van Kempen ZLE, Lövenich H, van Munster CEP, van Oosten BW, Smolders J, Vennegoor A, Zeinstra EMPE, Barrantes-Cepas M, Kooij G, Schoonheim MM, Lissenberg-Witte BI, Moraal B, Barkhof F, Uitdehaag BMJ, Mostert J, Teunissen CE, Killestein J, Strijbis EMM

Open source

DOI: 10.1007/s00415-025-13231-9
Published: 2025 Jul 23
Container: Journal of neurology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00415-025-13231-9,
  title = {Reliability of serum neurofilament light and glial fibrillary acidic protein for detecting disease activity upon discontinuation of first-line disease-modifying therapy in stable multiple sclerosis (DOT-MS).},
  author = {Fung WH and Wessels MHJ and Coerver EME and de Beukelaar J and Bouvy WH and Canta LR and Gerlach OHH and Hoitsma E and Hoogervorst ELJ and de Jong BA and Kalkers NF and van Kempen ZLE and Lövenich H and van Munster CEP and van Oosten BW and Smolders J and Vennegoor A and Zeinstra EMPE and Barrantes-Cepas M and Kooij G and Schoonheim MM and Lissenberg-Witte BI and Moraal B and Barkhof F and Uitdehaag BMJ and Mostert J and Teunissen CE and Killestein J and Strijbis EMM},
  year = {2025},
  journal = {Journal of neurology},
  doi = {10.1007/s00415-025-13231-9},
  url = {https://doi.org/10.1007/s00415-025-13231-9}
}

RIS

TY  - JOUR
TI  - Reliability of serum neurofilament light and glial fibrillary acidic protein for detecting disease activity upon discontinuation of first-line disease-modifying therapy in stable multiple sclerosis (DOT-MS).
AU  - Fung WH
AU  - Wessels MHJ
AU  - Coerver EME
AU  - de Beukelaar J
AU  - Bouvy WH
AU  - Canta LR
AU  - Gerlach OHH
AU  - Hoitsma E
AU  - Hoogervorst ELJ
AU  - de Jong BA
AU  - Kalkers NF
AU  - van Kempen ZLE
AU  - Lövenich H
AU  - van Munster CEP
AU  - van Oosten BW
AU  - Smolders J
AU  - Vennegoor A
AU  - Zeinstra EMPE
AU  - Barrantes-Cepas M
AU  - Kooij G
AU  - Schoonheim MM
AU  - Lissenberg-Witte BI
AU  - Moraal B
AU  - Barkhof F
AU  - Uitdehaag BMJ
AU  - Mostert J
AU  - Teunissen CE
AU  - Killestein J
AU  - Strijbis EMM
PY  - 2025
JO  - Journal of neurology
DO  - 10.1007/s00415-025-13231-9
UR  - https://doi.org/10.1007/s00415-025-13231-9
ER  -

APA

WH, F., MHJ, W., EME, C., J, D. B., WH, B., LR, C., OHH, G., E, H., ELJ, H., BA, D. J., NF, K., ZLE, V. K., H, L., CEP, V. M., BW, V. O., J, S., A, V., EMPE, Z., M, B., G, K., MM, S., BI, L., B, M., F, B., BMJ, U., J, M., CE, T., J, K., & EMM, S. (2025). Reliability of serum neurofilament light and glial fibrillary acidic protein for detecting disease activity upon discontinuation of first-line disease-modifying therapy in stable multiple sclerosis (DOT-MS).. Journal of neurology. https://doi.org/10.1007/s00415-025-13231-9

Source records

pubmed · retrieved 2026-09-26T09:39:02.025Z